Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05641519 · ClinicalTrials.gov registry record · NA

Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County

A NA study of Hypertension, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
483
Enrollment target
1
Study location

NCT05641519 is a NA study of Hypertension that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 483 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05641519, a NA study of Hypertension, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
483 participants
Enrollment target
1
Study location

Study Summary

The Skills-Based Educational strategies for Reduction of Vascular Events in Orange County, CA (SERVE OC) study aims to evaluate the efficacy of a culturally tailored, skills-based, cardiovascular health (CVH) intervention amongst a cohort of Latinx and Vietnamese families in Santa Ana, CA. The SERVE OC intervention was adapted from our previous work, the Discharge Educational Strategies for Reduction of Vascular Events (DESERVE) intervention, for the primordial prevention of hypertension (HTN) and other risk factors for cardiovascular disease (CVD). (The DESERVE study was conducted at New York University under their IRB). The intervention will be delivered by community health workers (CHWs) and will focus on: 1) optimizing risk perception, 2) enhancing provider-family communication, and 3) identifying challenges to CVH. Participants will receive multi-lingual materials and access to an app/web portal to identify healthy goals and strategies around modifiable risk factors for CVH, Life's Essential 8. SERVE OC will follow participants for 36-months to examine changes in CVH using Life's Simple 7 (LS7): smoking status, physical activity, weight, diet, blood glucose, cholesterol, and blood pressure (BP) scores and changes in systolic blood pressure (SBP) among adult participants versus enhanced standard intervention (ESI). Remote blood pressure (BP) monitoring will also be used to assess BP over time. CHWs will engage families in identifying barriers to CVH and solutions to share with community stakeholders. Using this community-based research (CBPR) approach the investigators hope to improve health equity within the community through enhanced social capital, empowerment, and advocacy capacity. This study is part of a multi-center projected coordinated by the UCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations (UC END-DISPARITIES), aimed at improving CVH among underserved populations in Los Angeles and Orange County.

Conditions Studied

Interventions

  • BEHAVIORAL SERVE OC Intervention
  • BEHAVIORAL Enhanced Standard Intervention

Study Locations (1)

California

  • University of California, Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 483 participants
Start Date 2022-11-18
Est. Completion 2026-07
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT05641519

The ClinicalTrials.gov registry entry for NCT05641519 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 483 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which SERVE OC Intervention is the first listed.

NCT05641519 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05641519 about?

NCT05641519 is a clinical study titled "Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County". The Skills-Based Educational strategies for Reduction of Vascular Events in Orange County, CA (SERVE OC) study aims to evaluate the efficacy of a culturally tailored, skills-based, cardiovascular health (CVH) intervention amongst a cohort of Latinx and Vietnamese families in Santa Ana, CA. The SERVE...

What is the current status of trial NCT05641519?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 483 participants. The study started on 2022-11-18. Estimated completion is 2026-07.

What conditions does trial NCT05641519 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05641519?

The interventions under investigation include: SERVE OC Intervention (BEHAVIORAL), Enhanced Standard Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05641519?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05641519 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.